ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease or Lou Gehrig's Disease, ...

Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The amyotrophic ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Many people will never know the last time they will do certain things in life. Even though he navigates sometimes trying days ...

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease that slowly robs people of their ability to move, speak, swallow, and even breathe.